Danielle Labbato
Overview
Explore the profile of Danielle Labbato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Desai A, Dirajlal-Fargo S, Durieux J, Tribout H, Labbato D, McComsey G
Open Forum Infect Dis
. 2021 Oct;
8(10):ofab408.
PMID: 34642636
Background: We investigated the association of vitamin K and vitamin D with coronavirus disease 2019 (COVID-19) outcomes. Methods: Levels of inactive vitamin K-dependent dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP; marker...
12.
Janus S, Al-Kindi S, Hajjari J, Chami T, Avery A, Labbato D, et al.
Am J Cardiol
. 2021 Jun;
152:179-180.
PMID: 34120703
No abstract available.
13.
Eckard A, Hughes H, Hagood N, ORiordan M, Labbato D, Kosco J, et al.
J Acquir Immune Defic Syndr
. 2020 Oct;
86(2):231-239.
PMID: 33065582
Background: Fecal calprotectin (FC), a biomarker of gastrointestinal (GI) inflammation, is used in the diagnosis and management of inflammatory bowel disease. HIV infection severely damages gut-associated lymphoid and epithelial tissues...
14.
Dirajlal-Fargo S, Albar Z, Bowman E, Labbato D, Sattar A, Karungi C, et al.
AIDS
. 2020 Feb;
34(7):1009-1018.
PMID: 32073452
Introduction: The pathophysiology of immune activation and its mechanisms in children living with perinatally acquired HIV (PHIV) in sub-Saharan Africa has been understudied. Methods: We enrolled 101 children living with...
15.
Eckard A, Hughes H, Hagood N, ORiordan M, Labbato D, Kosco J, et al.
J Acquir Immune Defic Syndr
. 2020 Jan;
83(5):e30-e33.
PMID: 31913998
No abstract available.
16.
Dirajlal-Fargo S, Albar Z, Bowman E, Labbato D, Sattar A, Karungi C, et al.
Clin Infect Dis
. 2019 Dec;
71(12):3025-3032.
PMID: 31807748
Background: The risk of cardiovascular disease (CVD) and its mechanisms in children living with perinatally acquired HIV (PHIV) in sub-Saharan Africa has been understudied. Methods: Mean common carotid artery intima-media...
17.
Eckard A, ORiordan M, Rosebush J, Lee S, Habib J, Ruff J, et al.
Antivir Ther
. 2017 Oct;
23(4):315-324.
PMID: 28994661
Background: Heightened immune activation and exhaustion drive HIV disease progression and comorbidities. Vitamin D has pleiotropic immunomodulatory effects, but little is known about the effects of supplementation in HIV. Our...
18.
Dirajlal-Fargo S, El Kamari V, Sattar A, Alam K, Funderburg N, Labbato D, et al.
Atherosclerosis
. 2017 Oct;
266:74-80.
PMID: 28992467
Background And Aims: Asymmetric dimethylarginine (ADMA) is an inhibitor of nitric oxide and an independent risk factor for cardiovascular disease. We examined the effect of statin on ADMA in HIV ...
19.
Eckard A, ORiordan M, Rosebush J, Ruff J, Chahroudi A, Labbato D, et al.
J Acquir Immune Defic Syndr
. 2017 Sep;
76(5):539-546.
PMID: 28902705
Background: Low bone mineral density (BMD) is a significant comorbidity in HIV. However, studies evaluating vitamin D supplementation on bone health in this population are limited. This study investigates changes...
20.
Eckard A, Raggi P, ORiordan M, Rosebush J, Labbato D, Chahroudi A, et al.
Virulence
. 2017 Sep;
9(1):294-305.
PMID: 28891732
No abstract available.